Skip to search formSkip to main contentSkip to account menu

P-glycoprotein Inhibitor

Known as: P-gp inhibitor 
Any compound or agent that acts to prevent the activity of P-glycoprotein.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Spontaneous hemopericardium and cardiac tamponade induced by dabigatran in combination with p-glycoprotein inhibitor
ABSTRACT Direct oral anticoagulants have been presented as a novel option for prevention and treatment of nonvalvular atrial… 
2015
2015
Inhibition of multidrug transporter in tumor endothelial cells enhances antiangiogenic effects of low-dose metronomic paclitaxel.
2013
2013
Development of a combinational drug-loaded nanoparticle for improving paclitaxel uptake into multidrug resistant breast cancer cells
SUMMARY Paclitaxel have been used in the treatment of wide range of cancers, but its entry into cancer cell is restricted by p… 
2004
2004
Toxicity of Quinacrine Can Be Reduced By Co-Administration of P-Glycoprotein Inhibitor in Sporadic Creutzfeldt-Jakob Disease
Abstract1. Recent publication has suggested that quinacrine may be a candidate for treatment of Creutzfeldt-Jakob disease (CJD… 
2004
2004
Effect of p-glycoprotein inhibitor combinations on drug efflux from rat brain microvessel endothelial cells.
In an effort to develop a clinically useful approach to inhibit the drug efflux across the blood brain barrier (BBB) mediated by… 
2004
2004
Effect of p-glycoprotein inhibitor combinations on drug efflux from rat brain microvessel endothelial cells.
In an effort to develop a clinically useful approach to inhibit the drug efflux across the blood brain barrier (BBB) mediated by… 
2003
2003
Combined treatment of Bcl-2 antisense oligodeoxynucleotides (G3139), p-glycoprotein inhibitor (PSC833), and sterically stabilized liposomal doxorubicin suppresses growth of drug-resistant growth of…
We studied the possibility of increasing sensitization of drug-resistant MDA435/LCC6 multidrug-resistant (MDR) human breast… 
2003
2003
The use of p-glycoprotein inhibitor surfactants at the surface of the colloidal carrier
Use of a colloidal carrier for the manufacture of a medicament for inhibiting P-glycoprotein, the colloidal carrier is: - a… 
2001
2001
Abundant expression of the microtubule-associated protein, ensconsin (E-MAP-115), alters the cellular response to Taxol.
Correlation between expression level of a microtubule-associated protein called ensconsin (E-MAP-115) and degree of Taxol… 
2000
2000
Contrasting effects of aspirin on prostate cancer cells: Suppression of proliferation and induction of drug resistance
Aspirin is widely used as a preventive measure against occlusive vascular diseases. Since the age group in which aspirin use has… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)